SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Eledon Presents Phase 2 BESTOW Trial Data at Kidney Week

Eledon Pharmaceuticals presented Phase 2 BESTOW trial data on tegoprubart compared with tacrolimus, reporting sustained improvements in quality of life and symptom burden.

ELDN

Related stories